(Press-News.org) LA JOLLA, CALIF. - Jan 20, 2020 - Scientists have identified two drugs that are potent against acute myeloid leukemia (AML) when combined, but only weakly effective when used alone. The researchers were able to significantly enhance cancer cell death by jointly administering the drugs that are only partially effective when used as single-agent therapies. The study, a collaboration between Sanford Burnham Prebys Medical Discovery Institute and the University of Glasgow, was recently published in the journal Nature Communications.
"Our study shows that two types of drugs, MDM2 inhibitors and BET inhibitors, work synergistically to promote significant anti-leukemia activity," says Peter Adams, Ph.D., a professor at Sanford Burnham Prebys and senior author of the study. "The results were surprising because previous research had shown that each drug on its own had modest benefit against AML. The new research provides scientific rationale to advance clinical studies of the drug combination in patients with AML."
There are many types of AML, and different cases have different chromosome changes, gene mutations and epigenetic modifications, making it difficult for researchers to find novel therapies that will work for a substantial proportion of patients. Although much progress has been made toward finding effective treatments in recent years, the long-term overall survival has stagnated. According to the American Cancer Society, the five-year survival rate for adults with AML remains less than 30%.
Notably, TP53, the most frequently mutated gene in all human cancers, is found unaltered in about 90% of AML patients. Since the product of the TP53 gene, p53, acts to suppress tumors, scientists have sought drugs that reactivate or boost its anti-cancer powers in AML, which should provide a clinical benefit. However, such drugs on their own have been disappointing in AML.
"We were interested in combining MDM2 and BET inhibitors because each showed encouraging pre-clinical activity, but limited activity when given to patients as a single agent," says Adams. "Previous research had shown that MDM2 inhibitors activate p53, and BET inhibitors suppress genes associated with leukemias--but not p53.
"Our research unexpectedly showed that like MDM2 inhibitors, BET inhibitors activate p53, but through a different pathway. BET inhibitors mute the power of a protein called BRD4, which we found is a p53 suppressor in AML," says Adams. "Between the two drugs, you end up with a 'double whammy' effect that fully unleashes the anti-cancer activity of p53.
"Better therapies for AML are desperately needed," adds Adams. "This study illustrates that targeting BRD4 as part of a combination therapy holds promise for patients diagnosed with this very dangerous disease."
INFORMATION:
The first authors of the study are Anne-Louise Latif and Ashley Newcombe of the University of Glasgow. Additional authors include Andrew Davis, Xue Lei and Sha Li of Sanford Burnham Prebys; Helen Stewart and Tim Chevassut of the University of Sussex; William Clark, Jennifer Morton, Lynn McGarry, Kevin M. Ryan and Jun-Ichi Sakamaki of the Beatson Institute (Glasgow); Claire McKeeve of Queen Elizabeth University Hospital (Glasgow); Brian Higgins of the Roche Innovation Center (New York); Sheela Abraham, Karen Blyth, Joana Campos, John Cole, Mhairi Copland, Kathryn Gilroy, Tessa Holyoake, Xu Huang, Karen Keeshan, Kristina Kirschner, Jonathan Lopez, Loveena Rishi, Neil Robertson, Stephen Tait and Maria Terradas of the University of Glasgow.
The study's DOI is 10.1038/s41467-020-20378-8.
This work was funded by CRUK program grant C10652/A16566, The Children with Cancer UK, the Howat Foundation, the Wellcome Trust (grant number 105641/Z/14/Z), the Sussex Cancer Fund, the CRUK Glasgow Centre (A25142), Core Services at the Cancer Research UK Beatson Institute (A17196), the Glasgow Experimental Cancer Medicine Centre, which is funded by Cancer Research UK and the Chief Scientist's Office, Scotland, and the Sussex Cancer Fund.
About Sanford Burnham Prebys Medical Discovery Institute
Sanford Burnham Prebys is a preeminent, independent biomedical research institute dedicated to understanding human biology and disease and advancing scientific discoveries to profoundly impact human health. For more than 40 years, our research has produced breakthroughs in cancer, neuroscience, immunology and children's diseases, and is anchored by our NCI-designated Cancer Center and advanced drug discovery capabilities. For more information, visit us at SBPdiscovery.org or on Facebook at facebook.com/SBPdiscovery and on Twitter @SBPdiscovery.
New research has demonstrated that a simple, cheap test can help identify who is at risk of developing colorectal cancer, aiding early diagnosis and potentially saving lives.
Led by the University of Exeter, and supported by the Peninsula and the Somerset, Wiltshire, Avon, and Gloucestershire Cancer Alliances, and by the Cancer Research UK CanTest Collaborative, a new study published today in the British Journal of Cancer examined data from nearly 4,000 patients aged 50 and over. The study involved all healthcare providers in the South West of England taking a new approach. ...
Successive governments' approach to obesity policies has destined them to fail, say researchers.
Government obesity policies in England over the past three decades have largely failed because of problems with implementation, lack of learning from past successes or failures, and a reliance on trying to persuade individuals to change their behaviour rather than tackling unhealthy environments. This is the conclusion of new research by a team at the University of Cambridge funded by the NIHR School for Public Health Research.
The researchers say their findings may help to explain why, after nearly thirty years of government obesity policies, obesity prevalence in England has not fallen and substantial inequalities persist. According to a report by NHS Digital in May 2020, ...
Young Seychelles warblers fare better if their elderly parents have help raising them, according to new research from the University of East Anglia (UEA) and the University of Groningen.
Seychelles warblers, a cooperatively breeding species of songbird that lives in small family groups, share the care of young between parents and helpers. This collaboration can compensate for a decline in the ability of elderly parents to provide sufficient care, the researchers found. It may also promote more social behaviour in family groups with older parents.
The findings help explain why social species, such as humans, often do better if they live in groups and cooperate to raise offspring.
The ...
Fried-food intake is linked to a heightened risk of major heart disease and stroke, finds a pooled analysis of the available research data, published online in the journal Heart.
And the risk rises with each additional 114 g weekly serving, the analysis indicates.
It's clear that the Western diet doesn't promote good cardiovascular health, but it's not clear exactly what contribution fried food might make to the risks of serious heart disease and stroke, say the researchers.
To shed some light on this, they trawled research databases, looking for relevant studies published up to April 2020, and found 19.
They pooled the data from 17, involving 562,445 participants ...
We should err on the side of caution and stop the global roll out of 5G (fifth generation) telecoms networks until we are certain this technology is completely safe, urges an expert in an opinion piece published online in the Journal of Epidemiology & Community Health.
There are no health concerns about 5G and COVID-19, despite what conspiracy theorists have suggested.
But the transmitter density required for 5G means that more people will be exposed to radio frequency electromagnetic fields (RF-EMFs), and at levels that emerging evidence suggests, are potentially harmful to health, argues Professor John William Frank, Usher Institute, University of Edinburgh.
The ...
Below please find summaries of new articles that will be published in the next issue of Annals of Internal Medicine. The summaries are not intended to substitute for the full articles as a source of information. This information is under strict embargo and by taking it into possession, media representatives are committing to the terms of the embargo not only on their own behalf, but also on behalf of the organization they represent.
1. Primary care physicians account for a minority of spending on low-value care
Abstract: https://www.acpjournals.org/doi/10.7326/M20-6257
URL goes live ...
BEER-SHEVA, Israel...January 18, 2021 - A green Mediterranean (MED) diet reduces intrahepatic fat more than other healthy diets and cuts non-alcoholic fatty liver disease (NAFLD) in half, according to a long-term clinical intervention trial led by Ben-Gurion University of the Negev researchers and a team of international colleagues.
The findings were published in Gut, a leading international journal focused on gastroenterology and hepatology.
"Our research team and other groups over the past 20 years have proven through rigorous randomized long-term trials that the Mediterranean diet is the healthiest," says lead researcher Prof. Iris Shai, an epidemiologist in the BGU ...
More people could be protected from life-threatening rabies thanks to an agile approach to dog vaccination using smart phone technology to spot areas of low vaccination coverage in real time.
Vets used a smart phone app to help them halve the time it takes to complete dog vaccination programmes in the Malawian city of Blantyre.
The custom-made app lets them quickly spot areas with low inoculation rates in real time, allowing them to jab more dogs more quickly, and with fewer staff.
Rabies is a potentially fatal disease passed on to humans primarily through dog bites. It is responsible for some 60,000 deaths worldwide each year, 40 per cent of which are children. It places a huge financial burden on some of the world's poorest countries.
Researchers predict that more than one million ...
CHAMPAIGN, Ill. -- Click beetles can propel themselves more than 20 body lengths into the air, and they do so without using their legs. While the jump's motion has been studied in depth, the physical mechanisms that enable the beetles' signature clicking maneuver have not. A new study examines the forces behind this super-fast energy release and provides guidelines for studying extreme motion, energy storage and energy release in other small animals like trap-jaw ants and mantis shrimps.
The multidisciplinary study, led by University of Illinois Urbana-Champaign mechanical science and ...
Scientists in Australia have developed a method for the rapid synthesis of safe vaccines, an approach that can be used to test vaccine strategies against novel pandemic pathogens such as SARS-CoV-2, the virus that causes COVID-19.
Led by Professor Richard Payne at the University of Sydney and Professor Warwick Britton at the Centenary Institute, the team has demonstrated application of the method with a new vaccine for use against tuberculosis (TB), which has generated a powerful protective immune response in mice.
Researchers are keen to develop the vaccine strategy further to assist in the rapid pre-clinical testing of new vaccines, particularly for respiratory illnesses.
"Tuberculosis infects 10 million and kills more than 1.4 million people every year," ...
